Clarus succeeds in invalidating four Lipocine testosterone patents

03-06-2021

Alex Baldwin

Clarus succeeds in invalidating four Lipocine testosterone patents

GrAl / Shutterstock.com

Clarus Therapeutics has convinced a US court to invalidate four Lipocine testosterone booster patents it was accused of infringing.


Clarus Therapeutics, Lipocine, District Court for the District of Delaware, invalidating, patents, William Bryson

LSIPR